Cyclodextrin Technologies Development

Cyclodextrin Technologies Development is a U.S.-based biotechnology company dedicated to marketing and selling cyclodextrin (CD) and related products for diagnostics, specialty pharmaceuticals, food, pharmaceuticals, and other industries. It continuously advances in research and new product development. The company offers Trappsol, Cyclo for the treatment of Niemann-Pick Type C disease (NPC), a fatal cholesterol metabolism disorder that primarily affects children and young adults.